Attovia Therapeutics, Inc. is a biopharmaceutical company developing precision multispecific biologics to address immune-mediated and inflammatory diseases, including dermatology conditions such as atopic dermatitis and chronic pruritus, and gastroenterology disorders like inflammatory bowel disease. The company is based in San Carlos, CA. The company utilizes its proprietary Attobody™ platform to design novel multispecific molecules that inhibit multiple disease-driving pathways. Key pipeline candidates include ATTO-1310 (anti-IL31) and ATTO-3712 (anti-IL31 x IL13), both in phase 1 clinical trials for chronic pruritus and inflammatory skin disease, and ATTO-1091, a trispecific molecule in IND-enabling stages for inflammatory bowel disease. The company was founded in 2022 by Petter Veiby, Tao Fu, Zaneta Odrowaz. Tao Fu has been the CEO of the company since 2022.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Attovia Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Attovia Therapeutics Inc. market cap is $880.13M.
What is the 52-week high for Attovia Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Attovia Therapeutics Inc. 52 week high is $24.32 as of August 27, 2026.
What is the 52-week low for Attovia Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Attovia Therapeutics Inc. 52 week low is $16.15 as of August 27, 2026.
What is Attovia Therapeutics Inc. stock price today?
Attovia Therapeutics Inc. stock price today is $19.55.
What was Attovia Therapeutics Inc. stock price yesterday?
Attovia Therapeutics Inc. stock price yesterday was $19.31.
What is the Price-to-Book ratio of Attovia Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Attovia Therapeutics Inc. P/B ratio is -6.7021.
What is the 50-day moving average of Attovia Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Attovia Therapeutics Inc. 50-day moving average is $20.21.